Biblio Discovery — Demo Discovery Service

5 hasil untuk "Mathilde Bahuaud"

Menampilkan 1–5 · 0,55 detik · RSS

  1. Artikel Jurnal

    Immunogenicity and persistence of a prime-boost re-vaccination strategy for pneumococcal vaccines in patients with rheumatoid arthritis

    Mathilde Bahuaud; Constance Beaudouin-Bazire; Marine Husson dkk.

    Human Vaccines & Immunotherapeutics, Vol. 14 No. 6 · 2018 · Inggris · DOAJ Scopus

    Objectives: Patients with rheumatoid arthritis (RA) are at an increased risk of Pneumococcal infections. Immunogenicity and persistence of a prime-boost revaccination strategy using 13-valent/23-valent anti-pneumococcal vaccines was evaluated in patients with RA treated by Methotrexate (MTX) and…

  2. Artikel Jurnal

    Immunogenicity and persistence of the 13-valent Pneumococcal Conjugate Vaccine (PCV13) in patients with untreated Smoldering Multiple Myeloma (SMM): A pilot study

    Mathilde Bahuaud; Hélène Bodilis; Marion Malphettes dkk.

    Heliyon, Vol. 3 No. 11 · 2017 · Inggris · DOAJ Scopus

    Smoldering multiple myeloma (SMM) is an asymptomatic clonal plasma cell disorder that frequently progress to multiple myeloma (MM), a disease at high risk of pneumococcal infections. Moreover, if the polysaccharide vaccine is poorly immunogenic in MM, the 13-valent conjugated vaccine has never been…

  3. Artikel Jurnal

    The 13-Valent Pneumococcal Conjugate Vaccine Elicits Serological Response and Lasting Protection in Selected Patients With Primary Humoral Immunodeficiency

    Ailsa Robbins; Mathilde Bahuaud; Maxime Hentzien dkk.

    Frontiers in Immunology, Vol. 12 · 2021 · Inggris · DOAJ Scopus

    BackgroundPatients with primary humoral immunodeficiency are more prone to invasive as well as recurrent pneumococcal infections. Therefore, anti-pneumococcal vaccination including the 13-valent conjugate vaccine is recommended. Nevertheless, to date, no data is available on immunogenicity of this…

  4. Artikel Jurnal

    Single-Dose 13-Valent Conjugate Pneumococcal Vaccine in People Living With HIV – Immunological Response and Protection

    Juliette Romaru; Mathilde Bahuaud; Gauthier Lejeune dkk.

    Frontiers in Immunology, Vol. 12 · 2021 · Inggris · DOAJ Scopus

    BackgroundPatients living with HIV (PLHIV) are prone to invasive pneumococcal disease. The 13-valent conjugated pneumococcal vaccine (PCV13) is currently recommended for all PLHIV, followed in most guidelines by a 23-valent polysaccharide pneumococcal vaccine. Data are scarce concerning the…

  5. Artikel Jurnal

    Value of the Overall Pneumococcal Polysaccharide Response in the Diagnosis of Primary Humoral Immunodeficiencies

    Benjamin Lopez; Mathilde Bahuaud; Claire Fieschi dkk.

    Frontiers in Immunology, Vol. 8 · 2017 · Inggris · DOAJ Scopus

    BackgroundAn overall response assay [OVA, based on a 23-valent pneumococcal polysaccharide vaccine (PPV23)] is widely used to screen for anti-pneumococcal antibodies. Given the heterogeneity of response from one polysaccharide (PS) to another, a World Health Organization-standardized…